@article{dd67065238ae47a5ade227cfe16c81a6,
title = "A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study",
author = "Kirschbaum, \{Mark H.\} and Paul Frankel and Synold, \{Timothy W.\} and Jasmine Zain and David Claxton and Joseph Tuscano and Newman, \{Edward M.\} and Gandara, \{David R.\} and Lara, \{Primo N.\}",
note = "Funding Information: This work was supported by the National Cancer Institute through the N01 CM-17101 Phase II Drug Development Contract (University of California at Davis) and UM1CA186717 (City of Hope), and included work performed in the Analytical Pharmacology Core under P30 CA033572 (City of Hope). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.",
year = "2018",
month = feb,
doi = "10.1111/bjh.14333",
language = "English (US)",
volume = "180",
pages = "445--448",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley and Sons Inc.",
number = "3",
}